Role(s) in Healthcare Innovation:

Accountant

Racheltu jordan

sales

100 Dollars Resume

United States

About Me

“Proteins that are engineered in the laboratory for pharmaceutical use are referred to as therapeutic proteins”. Protein-based therapeutics are highly successful in clinic and currently enjoy unprecedented recognition of their potential. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, autoimmunity/inflammation, exposure to infectious agents, and genetic disorders. Over the past 10 years, Creative BioMart has become a leader in discovery and manufacturing of recombinant proteins, providing quality products and services to our customers for both academic and industrial field.

Interested in solutions for:

For myself and those I love For my portfolio

I am looking for healthcare innovations:

You have not backed any projects. Lets change that!
Discover Projects

No project created yet. Lets change that!
Discover Projects

No comments on any project yet. Lets change that!
Discover Projects

No likes on any project yet.. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No project reviewed yet. Lets change that!
Discover Projects

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.